134 related articles for article (PubMed ID: 21638284)
1. Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.
Katori N; Sai K; Saito Y; Fukushima-Uesaka H; Kurose K; Yomota C; Kawanishi T; Nishimaki-Mogami T; Naito M; Sawada J; Kunitoh H; Nokihara H; Sekine I; Ohe Y; Yoshida T; Matsumura Y; Saijo N; Yamamoto N; Okuda H; Tamura T
J Pharm Sci; 2011 Oct; 100(10):4546-59. PubMed ID: 21638284
[TBL] [Abstract][Full Text] [Related]
2. CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population.
Saito Y; Katori N; Soyama A; Nakajima Y; Yoshitani T; Kim SR; Fukushima-Uesaka H; Kurose K; Kaniwa N; Ozawa S; Kamatani N; Komamura K; Kamakura S; Kitakaze M; Tomoike H; Sugai K; Minami N; Kimura H; Goto Y; Minami H; Yoshida T; Kunitoh H; Ohe Y; Yamamoto N; Tamura T; Saijo N; Sawada J
Pharmacogenet Genomics; 2007 Jul; 17(7):461-71. PubMed ID: 17558302
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients.
Fruscio R; Lissoni AA; Frapolli R; Corso S; Mangioni C; D'Incalci M; Zucchetti M
Cancer Chemother Pharmacol; 2006 Sep; 58(3):319-25. PubMed ID: 16362296
[TBL] [Abstract][Full Text] [Related]
4. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
Ohbatake Y; Fushida S; Tsukada T; Kinoshita J; Oyama K; Hayashi H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Yashiro M; Hirakawa K; Ohta T
Clin Exp Med; 2016 Nov; 16(4):585-592. PubMed ID: 26359244
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
6. The rearrangement of the human alpha(1)-acid glycoprotein/orosomucoid gene: evidence for tandemly triplicated genes consisting of two AGP1 and one AGP2.
Nakamura H; Yuasa I; Umetsu K; Nakagawa M; Nanba E; Kimura K
Biochem Biophys Res Commun; 2000 Sep; 276(2):779-84. PubMed ID: 11027547
[TBL] [Abstract][Full Text] [Related]
7. Orosomucoid (ORM) typing by isoelectric focusing: evidence for an additional duplicated ORM1 locus haplotype and close linkage of two ORM loci.
Yuasa I; Umetsu K; Suenaga K
Am J Hum Genet; 1988 Aug; 43(2):165-9. PubMed ID: 3400642
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of orosomucoid and alpha-2-HS-glycoprotein in a Philippine population.
Umetsu K; Yuasa I; Nishimura H; Sasaki H; Suzuki T
Hum Hered; 1988; 38(5):287-90. PubMed ID: 3235093
[TBL] [Abstract][Full Text] [Related]
9. Orosomucoid (ORM) typing by isoelectric focusing: evidence for several new variants including ORM1 and ORM2 silent alleles.
Yuasa I; Umetsu K; Suenaga K; Ikebuchi J; Suzuki T
Vox Sang; 1990; 58(2):129-34. PubMed ID: 2339522
[TBL] [Abstract][Full Text] [Related]
10. Investigation of genetic variants of alpha-1 acid glycoprotein by ultra-performance liquid chromatography-mass spectrometry.
Budai L; Ozohanics O; Ludányi K; Drahos L; Kremmer T; Krenyacz J; Vékey K
Anal Bioanal Chem; 2009 Feb; 393(3):991-8. PubMed ID: 19018521
[TBL] [Abstract][Full Text] [Related]
11. Use of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variants.
Tomei L; Eap CB; Baumann P; Dente L
Hum Genet; 1989 Dec; 84(1):89-91. PubMed ID: 2606483
[TBL] [Abstract][Full Text] [Related]
12. Orosomucoid in liver diseases.
Elpek GO
World J Gastroenterol; 2021 Dec; 27(45):7739-7747. PubMed ID: 34963738
[TBL] [Abstract][Full Text] [Related]
13. Orosomucoid (ORM) typing by isoelectric focusing: evidence for gene duplication of ORM1 and genetic polymorphism of ORM2.
Yuasa I; Suenaga K; Umetsu K; Ito K; Robinet-Levy M
Hum Genet; 1987 Nov; 77(3):255-8. PubMed ID: 3679210
[TBL] [Abstract][Full Text] [Related]
14. The structure and diversity of alpha1-acid glycoprotein/orosomucoid gene in Africans.
Yuasa I; Nakamura H; Umetsu K; Irizawa Y; Henke L; Henke J
Biochem Genet; 2006 Apr; 44(3-4):145-60. PubMed ID: 16670946
[TBL] [Abstract][Full Text] [Related]
15. Orosomucoid system: 17 additional orosomucoid variants and proposal for a new nomenclature.
Yuasa I; Weidinger S; Umetsu K; Suenaga K; Ishimoto G; Eap BC; Duche JC; Baumann P
Vox Sang; 1993; 64(1):47-55. PubMed ID: 8447119
[TBL] [Abstract][Full Text] [Related]
16. [Genetic polymorphisms of serum orosomucoid in Han population in Nanjing of China].
Li J; Xu J; Li Y; Zhuang Y; Gong J; Cai M; Cao W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Aug; 16(4):236-8. PubMed ID: 10431050
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of polymorphisms at the HAS alpha1-acid glycoprotein (ORM*) gene locus in Caucasians.
Owczarek CM; Owczarek AL; Board PG
Genet Mol Res; 2002 Mar; 1(1):96-105. PubMed ID: 14963818
[TBL] [Abstract][Full Text] [Related]
18. Orosomucoid (ORM) typing by isoelectric focusing: an analysis of ORM haplotypes.
Yuasa I; Umetsu K; Suenaga K; Iha M; Hirata H; Ikebuchi J
Hum Hered; 1990; 40(5):267-71. PubMed ID: 2265852
[TBL] [Abstract][Full Text] [Related]
19. Orosomucoid 1 and orosomucoid 2 types in the Taiwanese and Japanese: evidence for five new orosomucoid variants.
Umetsu K; Yuasa I; Chen ER; Kudo T; Suzuki T
Electrophoresis; 1988 May; 9(5):224-6. PubMed ID: 3234360
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levels.
Frapolli R; Zucchetti M; Sessa C; Marsoni S; Viganò L; Locatelli A; Rulli E; Compagnoni A; Bello E; Pisano C; Carminati P; D'Incalci M
Eur J Cancer; 2010 Feb; 46(3):505-16. PubMed ID: 20007015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
